Lawrence Biegelsen
Stock Analyst at Wells Fargo
(1.70)
# 3,412
Out of 5,127 analysts
57
Total ratings
48.65%
Success rate
-5.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lawrence Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Overweight | $350 → $360 | $292.89 | +22.91% | 6 | Nov 7, 2025 | |
| ABT Abbott Laboratories | Maintains: Overweight | $142 → $146 | $126.18 | +15.71% | 9 | Oct 16, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Equal-Weight | $172 → $184 | $205.18 | -10.32% | 5 | Aug 8, 2025 | |
| NPCE NeuroPace | Upgrades: Overweight | $16 → $20 | $16.96 | +17.92% | 7 | Mar 14, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Overweight | $166 → $82 | $22.50 | +264.44% | 5 | Aug 4, 2022 | |
| TFX Teleflex | Downgrades: Equal-Weight | $248 | $110.01 | +125.43% | 1 | Jul 29, 2022 | |
| ISRG Intuitive Surgical | Maintains: Overweight | $350 → $339 | $585.08 | -42.06% | 2 | Apr 22, 2022 | |
| REE REE Automotive | Initiates: Underweight | $1.5 | $0.80 | +87.27% | 1 | Mar 25, 2022 | |
| LUNG Pulmonx | Maintains: Equal-Weight | $55 → $27 | $2.10 | +1,185.71% | 3 | Feb 24, 2022 | |
| ZBH Zimmer Biomet Holdings | Maintains: Underweight | $124 → $111 | $94.08 | +17.98% | 2 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $144 | $68.43 | +110.07% | 1 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $56 | $114.15 | -50.94% | 4 | Jan 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $68 → $74 | $93.18 | -20.58% | 6 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $77 | $84.58 | -9.35% | 3 | Apr 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $85 → $90 | $14.87 | +505.25% | 1 | Mar 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | n/a | $94.62 | - | 1 | Dec 12, 2019 |
Insulet
Nov 7, 2025
Maintains: Overweight
Price Target: $350 → $360
Current: $292.89
Upside: +22.91%
Abbott Laboratories
Oct 16, 2025
Maintains: Overweight
Price Target: $142 → $146
Current: $126.18
Upside: +15.71%
Becton, Dickinson and Company
Aug 8, 2025
Maintains: Equal-Weight
Price Target: $172 → $184
Current: $205.18
Upside: -10.32%
NeuroPace
Mar 14, 2024
Upgrades: Overweight
Price Target: $16 → $20
Current: $16.96
Upside: +17.92%
Tandem Diabetes Care
Aug 4, 2022
Maintains: Overweight
Price Target: $166 → $82
Current: $22.50
Upside: +264.44%
Teleflex
Jul 29, 2022
Downgrades: Equal-Weight
Price Target: $248
Current: $110.01
Upside: +125.43%
Intuitive Surgical
Apr 22, 2022
Maintains: Overweight
Price Target: $350 → $339
Current: $585.08
Upside: -42.06%
REE Automotive
Mar 25, 2022
Initiates: Underweight
Price Target: $1.5
Current: $0.80
Upside: +87.27%
Pulmonx
Feb 24, 2022
Maintains: Equal-Weight
Price Target: $55 → $27
Current: $2.10
Upside: +1,185.71%
Zimmer Biomet Holdings
Feb 8, 2022
Maintains: Underweight
Price Target: $124 → $111
Current: $94.08
Upside: +17.98%
Jan 19, 2022
Upgrades: Overweight
Price Target: $144
Current: $68.43
Upside: +110.07%
Jan 19, 2022
Upgrades: Equal-Weight
Price Target: $56
Current: $114.15
Upside: -50.94%
Oct 29, 2021
Maintains: Equal-Weight
Price Target: $68 → $74
Current: $93.18
Upside: -20.58%
Apr 28, 2020
Downgrades: Equal-Weight
Price Target: $77
Current: $84.58
Upside: -9.35%
Mar 5, 2020
Upgrades: Overweight
Price Target: $85 → $90
Current: $14.87
Upside: +505.25%
Dec 12, 2019
Upgrades: Overweight
Price Target: n/a
Current: $94.62
Upside: -